King Pharmaceuticals KG Total — Reverse for loss and loss adjustment expenses

Other product segments

Similar metrics at other companies

SPNTReinsurance — Loss and loss adjustment expense reserves

$2.31B+5.9%

ORIReinsurance Recoverable — Loss and Loss Adjustment Expenses Reserves

$6.4B+10.2%

AXSReinsurance — Reserve for losses and loss expenses

$6.97B+3.7%

EGInsurance — Reserve for Losses and Loss Adjustment Expenses

$10.2B+15.4%

PGRLoss and loss adjustment expense reserves

$1.07B+39.5%

ESN

ESNTLoss and loss adjustment expense reserves

$38.84M+39.8%

Questions, answered.

What is King Pharmaceuticals's total — reverse for loss and loss adjustment expenses?

King Pharmaceuticals (KG) reported total — reverse for loss and loss adjustment expenses of $416.57M in Q4 2025.

What does total — reverse for loss and loss adjustment expenses mean?

This metric represents the total reserve established to cover the estimated costs of settling claims, including both the indemnity payments and the administrative expenses associated with claim processing. It is a fundamental indicator of the company's actuarial estimates regarding future claim obligations. Investors use this figure to evaluate the company's reserve strength and the potential for future earnings volatility resulting from reserve development.